Biolocity’s Post

In this week's episode, we are joined by Mathai Mammen, M.D., Ph.D., CEO & Chairman of FogPharma. Mathai joins host Alok Tayi, PhD as they discuss the development of a groundbreaking new class of therapeutics and the potential to revolutionize patient care. Listen to the episode: https://t.ly/_FIKi

🌟 Join the Sharpest Minds in RNAi at the 6th RNAi-Based Therapeutics Summit! 🌟 Whether you're a seasoned RNAi pro or intrigued by its groundbreaking potential, here's why this is the event you can't miss: 🧠 28 Expert Speakers - Leading voices in the RNAi space, sharing brand-new data on targeting the placenta, kidney, muscle and adipose tissue 💬 2 Round Table Discussions - Dive deep into the hottest industry topics and and RNAi innovations for future opportunities with peers 💼 1 Investor Panel - Led by Eli Lilly and Company, Sunrise BioVentures, and Broadview Ventures Inc, discover what’s next in RNAi and the key factors investors are looking for Download the OFFICIAL BROCHURE: https://ter.li/4cb7jb This summit will bring together fellow RNAi peers and YOU could be part of it! Don’t miss your chance to network, learn, and lead the way in RNAi-based therapies. #RNAiTherapeutics #RNAiInnovation 

🌟 Join the Sharpest Minds in RNAi at the 6th RNAi-Based Therapeutics Summit! 🌟 Whether you're a seasoned RNAi pro or intrigued by its groundbreaking potential, here's why this is the event you can't miss: 🧠 28 Expert Speakers - Leading voices in the RNAi space, sharing brand-new data on targeting the placenta, kidney, muscle and adipose tissue 💬 2 Round Table Discussions - Dive deep into the hottest industry topics and and RNAi innovations for future opportunities with peers 💼 1 Investor Panel - Led by Eli Lilly and Company, Sunrise BioVentures, and Broadview Ventures Inc, discover what’s next in RNAi and the key factors investors are looking for Download the OFFICIAL BROCHURE: https://ter.li/4cb7jb This summit will bring together fellow RNAi peers and YOU could be part of it! Don’t miss your chance to network, learn, and lead the way in RNAi-based therapies. #RNAiTherapeutics #RNAiInnovation 

Sharing an in-depth look at the “radiopharma” competitive landscape, courtesy of OPCO. Dive into the latest insights on this potentially impactful modality that is poised to change the standard of care in oncology! #biotech #healthcare #medicine #radiopharma #oncology #cancer

If you're looking to learn valuable tips for presenting science effectively, be sure to register for the webinar below ⤵

🗓 On International Clinical Trials Day 🩺, we thank the patients, clinicians, researchers and partners helping to advance our pipeline of potentially lifesaving therapeutics addressing rare and life-threatening liver conditions with high unmet medical needs. #ClinicalTrialsDay #CTD2024 #InternationalClinicalTrialsDay #InnovationInHealthcare ACRP - Association of Clinical Research Professionals

🔬 Exciting Updates in Clinical Trials! 🔬 🔹 Viridian Strive clinical trial is currently seeking Thyroid Eye Disease (TED) adult subjects! Eligible individuals can refer via the chat function on CockerhamMD.com for an intravenous dose of either 3 or 10 mg. Notably, there is no placebo arm for this trial. 🔹 Horizon/Amgen has successfully recruited their first subject for a clinical trial focusing on the transcutaneous delivery of a modified Tepezza molecule. The randomized process for this study is set to commence on July 9th. 🔹 In another recent development, the Genentech/Roche clinical trial is now live, with a primary focus on evaluating the efficacy of an IL6 monoclonal antibody. Stay tuned for more updates on these groundbreaking clinical trials! 🌟 #ClinicalTrials #Healthcare #MedicalResearch

I am prioritizing this panel discussion and look forward to learning from the experts!

🚀 Breaking Barriers in Digital Therapeutics 🌐 Join us for a masterclass on the future of early diagnosis in oncology featuring Mike Rosenbluth of Swing Therapeutics, Inc., and Tessy Huss of HLTH Community. The Challenge: Reimbursement Pathways for Digital Therapeutics (DTx) Despite the immense potential of DTx to transform healthcare, a lack of clear reimbursement pathways is hindering their widespread adoption. This impacts not only innovation but also limits patient access to potentially life-saving interventions. The Solution: Exploring Viable Commercialization Strategies Apply To Attend ➡️ https://lnkd.in/eSc3zBCj In the Masterclass, we'll explore: ✅ Overcoming reimbursement challenges in DTx ✅ Innovative business models for accessibility ✅ Future of DTx policies and frameworks Don't miss this opportunity to shape the future of healthcare! 💡 #DigitalTherapeutics #HealthcareInnovation #DTx #FutureOfMedicine Interested in learning more? Comment below! 👇

[BLOG POST] Dive Deeper into the Future of Therapeutics! Get ready for the next part of our ground-breaking blog series - 'The Future is Non-Viral,' where we delve even further into the exciting realm of therapeutic advancements. In this sequel, we continue to explore the insights shared by Ken LeClair, Chair of RoslinCT’s Scientific Advisory Board, uncovering the transformative potential of non-viral vector alternatives. Discover how cutting-edge cellular reprogramming techniques are revolutionizing the field and learn about the latest advancements that are reshaping tomorrow's therapies. Read the blog post: https://lnkd.in/ehQxp_an #TherapeuticDelivery #SABPerspectives #Roslinsights